Dr. Kate Knobil joins the biotech as it looks to combat a viral infection that can be dangerous to patients with the lung ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...

GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.

GSK (GSK) announced that the US CDC’s Advisory ... Recommendations made by the ACIP are reviewed and, if adopted, are published as official CDC recommendations. ACIP voted to recommend that ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

Cliff D’Arcy owns GSK shares. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...